Open Insider Trading Activity for G1 Therapeutics, Inc. Chief Financial Officer Umstead John W. V
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting GTHX | 2024-07-08 | 2024-07-05 | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Sell | 1 | 527 | $2.51 | $1,322.77 | 0.28% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting GTHX | 2024-05-15 | 2024-05-13 | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Sell | 1 | 8,151 | $4.79 | $39,043.29 | 5.05% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting GTHX | 2024-03-20 | 2024-03-18 | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Sell | 1 | 6,547 | $3.02 | $19,771.94 | 5.02% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting GTHX | 2024-01-08 | 2024-01-04 | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Sell | 3 | 743 | $3.09 | $2,298.18 | 0.19% | View Filing |